HK Stock Market Move | MICROTECH MED-B(02235) rose by more than 7%. The company is deeply implementing the layout of intelligent medical care, and institutions are optimistic about the future AI medical market scale.

MICROTECH MED-B(02235) rose more than 7%, as of the deadline, it increased by 7.05% to 5.16 Hong Kong dollars, with a turnover of 22.9886 million Hong Kong dollars. On the news front, it was reported that Huawei officially announced the formation of a medical health legion, focusing on the AI-assisted diagnosis field. Analysts pointed out that with the entry of tech giants such as Huawei, the technological iteration and commercialization of the AI medical industry are expected to further accelerate. Soochow research report pointed out that AI medical is becoming the core drive of the medical industry transformation, and the size of China's AI medical market is expected to exceed 150 billion yuan by 2030, with significant growth in sub-sectors such as AI imaging, surgical Siasun Robot & Automation. Policy support combined with technological progress will promote the landing of AI in disease diagnosis, health management, drug research and development, etc., and it is recommended to pay attention to structural opportunities in areas such as image recognition, pathological diagnosis, and health management. Weitai Medical pointed out that as a leading domestic diabetes management company, the company has been deeply involved in the layout of intelligent medical care since its establishment. Relying on AI large models, Weitai Medical will also fully upgrade the artificial intelligence service system, further launch a full-chain medical AI product matrix around the needs of doctors, pharmacies, and patients, achieve deep integration of cutting-edge A technology with CGM products and artificial pancreas solutions, and promote the strategic transformation from passive disease management to active health intervention in chronic disease management mode. With the core platform of Jian Tang + intelligent management system, Weitai Medical has built an intelligent application system covering the full disease management of diabetes and related chronic diseases, realizing a centralized and integrated intelligent management centered on diabetes. This system has been applied in more than 3,500 hospitals, accumulating real-world data from millions of patients.